Image-guided robotic radiosurgery for glomus jugulare tumors-Multicenter experience and review of the literature.
CyberKnife
glomus jugulare
paraganglioma
radiosurgery
review
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
07
05
2020
revised:
14
07
2020
accepted:
14
08
2020
pubmed:
28
8
2020
medline:
22
6
2021
entrez:
28
8
2020
Statut:
ppublish
Résumé
Glomus jugulare tumors (GJTs) are challenging to treat due to their vascularization and location. This analysis evaluates the effectiveness and safety of image-guided robotic radiosurgery (RRS) for GJTs in a multicenter study and reviews the existing radiosurgical literature. We analyzed outcome data from 101 patients to evaluate local control (LC), changes in pretreatment deficits, and toxicity. Moreover, radiosurgical studies for GJTs have been reviewed. After a median follow-up of 35 months, the overall LC was 99%. Eighty-eight patients were treated with a single dose, 13 received up to 5 fractions. The median tumor volume was 5.6 cc; the median treatment dose for single-session treatments is 16 Gy, and for multisession treatments is 21 Gy. Fifty-six percentage of patients experienced symptom improvement or recovered entirely. RRS is an effective primary and secondary treatment option for GJTs. The available literature suggests that radiosurgery is a treatment option for most GJTs.
Sections du résumé
BACKGROUND
Glomus jugulare tumors (GJTs) are challenging to treat due to their vascularization and location. This analysis evaluates the effectiveness and safety of image-guided robotic radiosurgery (RRS) for GJTs in a multicenter study and reviews the existing radiosurgical literature.
METHODS
We analyzed outcome data from 101 patients to evaluate local control (LC), changes in pretreatment deficits, and toxicity. Moreover, radiosurgical studies for GJTs have been reviewed.
RESULTS
After a median follow-up of 35 months, the overall LC was 99%. Eighty-eight patients were treated with a single dose, 13 received up to 5 fractions. The median tumor volume was 5.6 cc; the median treatment dose for single-session treatments is 16 Gy, and for multisession treatments is 21 Gy. Fifty-six percentage of patients experienced symptom improvement or recovered entirely.
CONCLUSIONS
RRS is an effective primary and secondary treatment option for GJTs. The available literature suggests that radiosurgery is a treatment option for most GJTs.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
35-47Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Moffat DA, Hardy DG. Surgical management of large glomus jugulare tumours: infra- and trans-temporal approach. J Laryngol Otol. 1989;103(12):1167-1180.
Gulya AJ. The glomus tumor and its biology. Laryngoscope. 1993;103(11 Pt 2 Suppl 60):7-15.
Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94(3):730-737.
Forbes JA, Brock AA, Ghiassi M, Thompson RC, Haynes DS, Tsai BS. Jugulotympanic paragangliomas: 75 years of evolution in understanding. Neurosurg Focus. 2012;33(2):E13.
Lieberson RE, Adler JR, Soltys SG, Choi C, Gibbs IC, Chang SD. Stereotactic radiosurgery as the primary treatment for new and recurrent paragangliomas: is open surgical resection still the treatment of choice? World Neurosurg. 2012;77(5-6):745-761.
Gottfried ON, Liu JK, Couldwell WT. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus. 2004;17(2):E4.
Suarez C, Rodrigo JP, Bodeker CC, et al. Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy. Head Neck. 2013;35(8):1195-1204.
Guss ZD, Batra S, Limb CJ, et al. Radiosurgery of glomus jugulare tumors: a meta-analysis. Int J Radiat Oncol Biol Phys. 2011;81(4):e497-e502.
Tripathi M, Rekhapalli R, Batish A, et al. Safety and efficacy of primary multisession dose fractionated gamma knife radiosurgery for jugular Paragangliomas. World Neurosurg. 2019;131:e136-e148.
Gigliotti MJ, Hasan S, Liang Y, Chen D, Fuhrer R, Wegner RE. A 10-year experience of linear accelerator-based stereotactic radiosurgery/radiotherapy (SRS/SRT) for paraganglioma: a single institution experience and review of the literature. J Radiosurg SBRT. 2018;5(3):183-190.
Sallabanda K, Barrientos H, Isernia Romero DA, et al. Long-term outcomes after radiosurgery for glomus jugulare tumors. Tumori. 2018;104(4):300-306.
Hafez RFA, Morgan MS, Fahmy OM, Hassan HT. Long-term effectiveness and safety of stereotactic gamma knife surgery as a primary sole treatment in the management of glomus jagulare tumor. Clin Neurol Neurosurg. 2018;168:34-37.
Sharma M, Meola A, Bellamkonda S, et al. Long-term outcome following stereotactic radiosurgery for glomus Jugulare tumors: a single institution experience of 20 years. Neurosurgery. 2018;83(5):1007-1014.
Patel NS, Carlson ML, Pollock BE, et al. Long-term tumor control following stereotactic radiosurgery for jugular paraganglioma using 3D volumetric segmentation. J Neurosurg. 2018;1-9. https://doi.org/10.3171/2017.10.JNS17764
Ibrahim R, Ammori MB, Yianni J, Grainger A, Rowe J, Radatz M. Gamma knife radiosurgery for glomus jugulare tumors: a single-center series of 75 cases. J Neurosurg. 2017;126(5):1488-1497.
Wakefield DV, Venable GT, VanderWalde NA, et al. Comparative neurologic outcomes of salvage and definitive gamma knife radiosurgery for glomus Jugulare: a 20-year experience. J Neurol Surg B Skull Base. 2017;78(3):251-255.
Winford TW, Dorton LH, Browne JD, Chan MD, Tatter SB, Oliver ER. Stereotactic radiosurgical treatment of glomus jugulare tumors. Otol Neurotol. 2017;38(4):555-562.
Dobberpuhl MR, Maxwell S, Feddock J, St Clair W, Bush ML. Treatment outcomes for single modality management of glomus jugulare tumors with stereotactic radiosurgery. Otol Neurotol. 2016;37(9):1406-1410.
El Majdoub F, Hunsche S, Igressa A, Kocher M, Sturm V, Maarouf M. Stereotactic LINAC-radiosurgery for glomus jugulare tumors: a long-term follow-up of 27 patients. PLoS One. 2015;10(6):e0129057.
Gandia-Gonzalez ML, Kusak ME, Moreno NM, Sarraga JG, Rey G, Alvarez RM. Jugulotympanic paragangliomas treated with gamma knife radiosurgery: a single-center review of 58 cases. J Neurosurg. 2014;121(5):1158-1165.
Sager O, Beyzadeoglu M, Dincoglan F, et al. Evaluation of linear accelerator-based stereotactic radiosurgery in the management of glomus jugulare tumors. Tumori. 2014;100(2):184-188.
Hurmuz P, Cengiz M, Ozyigit G, et al. Robotic stereotactic radiosurgery in patients with unresectable glomus jugulare tumors. Technol Cancer Res Treat. 2013;12(2):109-113.
de Andrade EM, Brito JR, Mario SD, de Melo SM, Benabou S. Stereotactic radiosurgery for the treatment of glomus Jugulare tumors. Surg Neurol Int. 2013;4(Suppl 6):S429-S435.
Sheehan JP, Tanaka S, Link MJ, et al. Gamma knife surgery for the management of glomus tumors: a multicenter study. J Neurosurg. 2012;117(2):246-254.
Chen PG, Nguyen JH, Payne SC, Sheehan JP, Hashisaki GT. Treatment of glomus jugulare tumors with gamma knife radiosurgery. Laryngoscope. 2010;120(9):1856-1862.
Genc A, Bicer A, Abacioglu U, Peker S, Pamir MN, Kilic T. Gamma knife radiosurgery for the treatment of glomus jugulare tumors. J Neurooncol. 2010;97(1):101-108.
Navarro Martin A, Maitz A, Grills IS, et al. Successful treatment of glomus jugulare tumours with gamma knife radiosurgery: clinical and physical aspects of management and review of the literature. Clin Transl Oncol. 2010;12(1):55-62.
Ganz JC, Abdelkarim K. Glomus jugulare tumours: certain clinical and radiological aspects observed following gamma knife radiosurgery. Acta Neurochir. 2009;151(5):423-426.
Miller JP, Semaan M, Einstein D, Megerian CA, Maciunas RJ. Staged gamma knife radiosurgery after tailored surgical resection: a novel treatment paradigm for glomus jugulare tumors. Stereotact Funct Neurosurg. 2009;87(1):31-36.
Sharma MS, Gupta A, Kale SS, Agrawal D, Mahapatra AK, Sharma BS. Gamma knife radiosurgery for glomus jugulare tumors: therapeutic advantages of minimalism in the skull base. Neurol India. 2008;56(1):57-61.
Lim M, Bower R, Nangiana JS, Adler JR, Chang SD. Radiosurgery for glomus jugulare tumors. Technol Cancer Res Treat. 2007;6(5):419-423.
Bitaraf MA, Alikhani M, Tahsili-Fahadan P, et al. Radiosurgery for glomus jugulare tumors: experience treating 16 patients in Iran. J Neurosurg. 2006;105:168-174.
Feigl GC, Horstmann GA. Intracranial glomus jugulare tumors: volume reduction with gamma knife surgery. J Neurosurg. 2006;105(Suppl):161-167.
Gerosa M, Visca A, Rizzo P, Foroni R, Nicolato A, Bricolo A. Glomus jugulare tumors: the option of gamma knife radiosurgery. Neurosurgery. 2006;59(3):561-569.
Poznanovic SA, Cass SP, Kavanagh BD. Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors. Otolaryngol Head Neck Surg. 2006;134(3):437-442.
Eustacchio S, Trummer M, Unger F, Schrottner O, Sutter B, Pendl G. The role of gamma knife radiosurgery in the management of glomus jugular tumours. Acta Neurochir Suppl. 2002;84:91-97.
Saringer W, Khayal H, Ertl A, Schoeggl A, Kitz K. Efficiency of gamma knife radiosurgery in the treatment of glomus jugulare tumors. Minim Invasive Neurosurg. 2001;44(3):141-146.
Pollock BE, Foote RL. The evolving role of stereotactic radiosurgery for patients with skull base tumors. J Neurooncol. 2004;69(1-3):199-207.
Shapiro S, Kellermeyer B, Ramadan J, Jones G, Wiseman B, Cassis A. Outcomes of primary radiosurgery treatment of glomus jugulare tumors: systematic review with meta-analysis. Otol Neurotol. 2018;39(9):1079-1087.
Fayad JN, Keles B, Brackmann DE. Jugular foramen tumors: clinical characteristics and treatment outcomes. Otol Neurotol. 2010;31(2):299-305.
Sanna M, De Donato G, Piazza P, Falcioni M. Revision glomus tumor surgery. Otolaryngol Clin North Am. 2006;39(4):763-782.
Jackson CG, Kaylie DM, Coppit G, Gardner EK. Glomus jugulare tumors with intracranial extension. Neurosurg Focus. 2004;17(2):E7.
Nonaka Y, Fukushima T, Watanabe K, et al. Less invasive transjugular approach with fallopian bridge technique for facial nerve protection and hearing preservation in surgery of glomus jugulare tumors. Neurosurg Rev. 2013;36(4):579-586.
Borba LA, Araújo JC, de Oliveira JG, et al. Surgical management of glomus jugulare tumors: a proposal for approach selection based on tumor relationships with the facial nerve. J Neurosurg. 2010;112(1):88-98.
Piras G, Mariani-Costantini R, Sanna M. Are Ouctomes of radiosurgery for Tympanojugular Paraganglioma overestimated? Otol Neurotol. 2019;40(5):688-689.
Prasad SC, Mimoune HA, D'Orazio F, et al. The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas. Otol Neurotol. 2014;35(5):922-931.
Cama A, Verginelli F, Lotti LV, et al. Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. Acta Neuropathol. 2013;126(4):575-594.
Verginelli F, Perconti S, Vespa S, et al. Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib. Acta Neuropathol. 2018;135(5):779-798.
Lin J, Liu C, Gao F, et al. miR-200c enhances radiosensitivity of human breast cancer cells. J Cell Biochem. 2013;114(3):606-615.
van Hulsteijn LT, Louisse A, Havekes B, et al. Quality of life is decreased in patients with paragangliomas. Eur J Endocrinol. 2013;168(5):689-697.
Galland-Girodet S, Maire JP, De-Mones E, et al. The role of radiation therapy in the management of head and neck paragangliomas: impact of quality of life versus treatment response. Radiother Oncol. 2014;111(3):463-467.
Patel NS, Link MJ, Tombers NM, Pollock BE, Carlson ML. Quality of life in jugular Paraganglioma following radiosurgery. Otol Neurotol. 2019;40(6):820-825.
Henzel M, Hamm K, Gross MW, et al. Fractionated stereotactic radiotherapy of glomus jugulare tumors. Local control, toxicity, symptomatology, and quality of life. Strahlenther Onkol. 2007;183(10):557-562.
Ehret F, Kufeld M, Fürweger C, et al. Single-session image-guided robotic radiosurgery and quality of life for glomus jugulare tumors. Head Neck. 2020;42:2421-2430.
Neves F, Huwart L, Jourdan G, et al. Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography. AJNR Am J Neuroradiol. 2008;29(5):883-889.
van den Berg R, Schepers A, de Bruïne FT, et al. The value of MR angiography techniques in the detection of head and neck paragangliomas. Eur J Radiol. 2004;52(3):240-245.
Larson TC 3rd, Reese DF, Baker HL Jr, McDonald TJ. Glomus tympanicum chemodectomas: radiographic and clinical characteristics. Radiology. 1987;163(3):801-806.
Lo WW, Solti-Bohman LG, Lambert PR. High-resolution CT in the evaluation of glomus tumors of the temporal bone. Radiology. 1984;150(3):737-742.
Spina A, Boari N, Gagliardi F, et al. Gamma knife radiosurgery for glomus tumors: long-term results in a series of 30 patients. Head Neck. 2018;40(12):2677-2684.